Hvax Technologies H1 FY26 Income Jumps 35%
Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.
Category : Search result: pharmaceutical company India
Punjab Health Minister's Stern Warning to Drug Manufacturers
Punjab Health Minister Dr Balbir Singh issues strict quality warning to drug manufacturers after MP cough syrup incident. State adopts zero-tolerance policy on sub-standard medicines.
India Urges Russia to Fast-Track Export Approvals
India requests Russia to expedite approvals for Indian exporters in marine, pharmaceutical sectors during Moscow talks. Bilateral trade targets $100B by 2030. Key discussions ahead of Putin's December visit.
FSSAI bans misleading ORS ads, FDC's Electral validated
FSSAI cracks down on false ORS marketing claims. FDC Ltd welcomes action, reaffirming Electral's 50-year scientific legacy as genuine electrolyte solution.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
India Pushes Russia for Faster Approvals to Boost Trade
India urges Russia to expedite approvals for marine and pharmaceutical products during Moscow talks. Bilateral trade currently at $25 billion, targeting $100 billion by 2030.
Bry-Air Launches P80X MOF Dehumidifier for Pharma
Bry-Air introduces P80X, the most advanced MOF-technology dehumidifier for pharmaceutical manufacturing. Ensures precise humidity control for quality compliance.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Bharuch's Saykha GIDC leaves 2 workers dead, 20 injured. Fire brigade and investigation teams on site. Read latest updates.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
FDA Names Dr. Richard Pazdur as New Drug Center Director
The FDA appoints veteran cancer regulator Dr. Richard Pazdur to lead its drug center following the ouster of Dr. George Tidmarsh over ethics concerns. Learn about the challenges ahead.
Granules India Gets USFDA Approval for Hyderabad Plant
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
Fujiyama Power Systems IPO Opens Nov 13: Details
Fujiyama Power Systems launches ₹828 crore IPO from Nov 13-17. Learn about price band, financial performance, and key risks before investing in this solar energy company.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Kalyan Jewellers Q2 Profit Soars 100% to ₹260 Cr
Kalyan Jewellers reports stellar Q2 FY2024 results with net profit doubling to ₹260 crore and revenue surging 30% year-on-year. Discover how India's love for gold is driving this spectacular growth.
DESCO Infratech Strong H1 FY2025 Results
DESCO Infratech Limited announces impressive financial performance for H1 FY2025, reporting significant revenue growth and profitability while reaffirming strong projections for H2.
StarRez Picks Hyderabad for APAC SaaS Hub
Global student housing SaaS leader StarRez announces major APAC expansion in Hyderabad, creating 150+ tech jobs and establishing India as strategic innovation hub for global operations.
Mitsu Chem Plast Q2 Profit Jumps 66%
Mitsu Chem Plast Limited reports outstanding Q2 FY26 results with 66% net profit growth and 11% revenue increase, showcasing robust financial health and operational excellence.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Curis Lifesciences IPO: 17x Subscription on Day 1
Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.
Shreeji Global FMCG ₹85 Crore IPO Closes Nov 7
Shreeji Global FMCG Limited launches ambitious ₹85 crore IPO to fuel expansion and strengthen market position. Discover key dates, price band, and growth plans.
SBI's $100B Turnaround: From Losses to Banking Giant
Discover how State Bank of India transformed from a loss-making entity in 2018 into a $100 billion financial giant, driven by strategic regulatory reforms implemented by RBI Governor Malhotra.
Pharma Executive Collapses in Oval Office During Trump Meeting
A high-stakes White House meeting on weight-loss drug prices took a dramatic turn when a pharmaceutical executive suddenly collapsed, forcing an abrupt end to Donald Trump's briefing. The viral video has sparked nationwide concern.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Nilkamal Q2 Profit Surges 18% on B2B, E-commerce Growth
Nilkamal Ltd reports stellar Q2 FY2024 results with 18% profit growth driven by strong B2B and e-commerce performance. Revenue climbs as plastic furniture giant expands market reach.
DRI Busts Illegal Alprazolam Factory in Gujarat
In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.
Page 1 of 4